Library

feed icon rss

Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
  • 1
    ISSN: 1600-079X
    Source: Blackwell Publishing Journal Backfiles 1879-2005
    Topics: Medicine
    Notes: Abstract: It has been demonstrated that antitumor immune response is an IL-2-dependent phenomenon. Moreover, experimental results suggest the existence of interactions between IL-2 and the pineal gland, which also plays a role in the control of immunity and cancer growth.Alterations of both IL-2 and melatonin secretion have been reported in cancer patients. To further investigate pineal/IL-2 relationships in humans with cancer, we evaluated the melatonin rhythm in seven advanced small cell lung cancer patients, before and at weekly intervals during immunotherapy with IL-2, given subcutaneously at a daily dose of 3 × 106 IU/m2 twice daily for 5 days/week for 4 weeks. Before IL-2, no patient showed a light/dark rhythm of melatonin. IL-2 administration induced a normalization of the melatonin circadian rhythm, with the appearance of a night time peak in 4/7 patients. This effect, however, disappeared with IL-2 interruption in 3/4 patients. This preliminary study, by showing that IL-2 may restore a normal melatonin rhythm, suggests that the anomalous pineal function in cancer may depend at least in part on the altered endogenous IL-2 production.
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 2
    ISSN: 1600-079X
    Source: Blackwell Publishing Journal Backfiles 1879-2005
    Topics: Medicine
    Notes: Experimental studies have suggested that the pineal hormone melatonin, in addition to its documented antineoplastic action, plays a role in the physiological regulation of blood cell proliferation. Based on these data, we evaluated the clinical effects of melatonin therapy in patients with myelodysplastic syndrome (MDS) secondary to cancer chemotherapy for primary neoplasms. The study was carried out on six patients, and melatonin was given orally at a dose of 20 mg/daily, following a schedule prepared to reproduce the circadian rhythm of the pineal hormone. A transient improvement in platelet and neutrophil count was achieved in two of five patients with thrombocytopenia and in two of four patients with neutropenia before therapy, respectively, while no effect was seen on hemoglobin concentration. Mean survival time was 12.5 months, and a long survival, greater than 30 months, was achieved in two of six patients. These preliminary results seem to suggest that melatonin may have a role in the treatment of MDS induced by previous cancer chemotherapy.
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 3
    ISSN: 1569-8041
    Keywords: computed tomography ; gallium scan ; magnetic resonance ; mediastinal Hodgkin's disease
    Source: Springer Online Journal Archives 1860-2000
    Topics: Medicine
    Notes: Abstract Background: In patients with Hodgkin's disease, the use of gallium-67scintigraphy (Ga-67) compared to conventional staging and restaging techniquesis still controversial. In particular, in a combined modality treatment withchemotherapy and radiotherapy given in sequence, its role in detecting activedisease after chemotherapy may be useful in planning the subsequentradiotherapeutic strategy. Patients and methods: From March 1990 to September 1994, 125 patientswith previously untreated histologically proven Hodgkin's disease wereenrolled in two different prospective trials according to clinical stage.Staging procedures included Ga-67, chest-abdominal computed tomography (CT),and/or magnetic resonance (MR). All three tests were performed in 53patients at staging and in 47 at restaging. Results of Ga-67 at staging werecompared to conventional procedures or pathological findings. Results ofGa-67, CT scan, and MR at restaging were compared to disease outcome duringthe follow-up. Finally a cost/benefit ratio for each test was determined. Results: At staging, Ga-67 showed lower sensitivity than CT and MR(90 vs. 96 and 100%, respectively) because of the number offalse-negative images. Nevertheless, by using both CT and Ga-67 scan, thesensitivity is equal to that observed with MR (100%). At restaging,Ga-67 is superior to CT scan and equivalent to MR in detecting true negativepatients (specificity: 98% vs. 45% vs. 92%). Conclusions: As a single technique, Ga-67 scan cannot substitute forCT scan or MR in staging patients with Hodgkin's disease. Nevertheless, Ga-67scan has an important role in defining complete remission after treatment andtherefore in planning subsequent treatment. Considering the lower costs of CTscan plus Ga-67 ($320) versus MR alone ($810), the twotests may be considered procedures of choice in staging as well as inrestaging patients with Hodgkin's disease.
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
Close ⊗
This website uses cookies and the analysis tool Matomo. More information can be found here...